4:08pm ET
Investing
Tuesday’s Biggest Winner and Losers in the S&P 500
Tuesday was a positive day for the broad U.S. markets, with the S&P 500 hitting a new all-time high in the session. Crude oil again took a small step forward in the…
Companies
/Healthcare
Medtronic Plc
$91.11
â–² $1.14 (+1.27%) today
Markets open · 2:03pm ET
MDT Coverage
Page 811:50am ET
Health and Healthcare
Why Merrill Lynch Sees Health Care Sector Offering Solid Growth, and as Value and Defensive
The latest monthly Merrill Lynch RIC Report is quite favorable on the health care sector as an opportunity for investors. Here we identify some of the top health care picks.
8:45am ET
Investing
Top Analyst Upgrades and Downgrades: AT&T, Abbott Labs, Honeywell, Tiffany, Zimmer Biomet and More
The top analyst upgrades, downgrades and other research calls from Wednesday include AT&T, Abbott Laboratories, Honeywell, Tiffany and Zimmer Biomet.
8:50am ET
Investing
Top Analyst Upgrades and Downgrades: Alkermes, Cigna, International Paper, Medtronic, Tesla, Western Digital and More
The top analyst upgrades, downgrades and other research calls from Wednesday include Alkermes, Cigna, International Paper, Medtronic, Tesla and Western Digital.
9:10am ET
Investing
Top Analyst Upgrades and Downgrades: Starbucks, Splunk, PayPal, L Brands, Medtronic, Gap, Novartis and More
The top analyst upgrades, downgrades and other research calls from Friday include Starbucks, Splunk, PayPal, L Brands, Medtronic, Gap and Novartis.
9:55am ET
Health and Healthcare
UBS Makes Big Health Care Swap in Top Performing Q-GARP Portfolio
Managers of the UBS Q-GARP portfolio continue searching for high-quality U.S. growth companies that are trading at attractive valuations. They maintain that recent volatility in the market has had no impact on…
4:08pm ET
Investing
Monday’s Biggest Winners and Losers in the S&P 500
Monday was a decent day for the broad U.S. markets. Crude oil touched above $70 in the session but ultimately retreated by the close. The S&P 500 sectors were more or less…
8:25am ET
Investing
10 Stocks to Buy Now in Case 2019 Bear Market Does Come
The Stifel view is that it is time for investors to take a more defensive posture, but that doesn’t mean selling everything and going to cash.
8:41am ET
Investing
10 Top Irish Stocks Worth Keeping an Eye On
Here are 10 top Ireland-based public companies with shares that are traded in the United States that may be worth putting on a watchlist.
8:55am ET
Investing
Top Analyst Upgrades and Downgrades: Freeport-McMoRan, Medtronic, Northrup Grumman, SailPoint, Stitch Fix, Verizon and More
The top analyst upgrades, downgrades and other research calls from Tuesday include Freeport-McMoRan, Medtronic, Northrup Grumman, SailPoint, Stitch Fix and Verizon.
9:05am ET
Investing
Top Analyst Upgrades and Downgrades: Ctrip, Goldman Sachs, Johnson & Johnson, Medtronic, Morgan Stanley, Yelp, Yum China and More
The top analyst upgrades, downgrades and other research calls from Monday include Ctrip.com, Goldman Sachs, Johnson & Johnson, Medtronic, Morgan Stanley, Yelp and Yum China.
10:10am ET
Health and Healthcare
Mazor Robotics Jumps After Medtronic Collaboration Update
Mazor Robotics saw its shares make a handy gain to kick off hump day after it was announced that the company has entered the next phase of its strategic partnership with Medtronic…
Chris Lange 10:15am ET
Investing
UBS Dividend Ruler Stocks Keep Raising Payouts: 4 to Buy Now
While not cheap, these stock present among the best ideas for growth and income accounts now. There is every reason to believe they will continue raising cash dividends to shareholders.
8:55am ET
Investing
Top Analyst Upgrades and Downgrades: AutoZone, O’Reilly Automotive, Immunogen, Medtronic, Nike, OncoSec, Schlumberger and More
The top analyst upgrades, downgrades and other research calls from Thursday include AutoZone, O'Reilly Automotive, Immunogen, Medtronic, Nike, OncoSec Medical and Schlumberger.
10:15am ET
Investing
4 Large Cap Leaders Dominate Top Jefferies Stocks to Buy
These four large cap leaders that have a value profile look attractive now for investors trying to play it a little safer for the second half of 2017.